These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9826044)

  • 1. Management of Irish patients with intraocular melanoma referred to Liverpool, England.
    Kent D; Noonan CP; Damato BE
    Acta Ophthalmol Scand; 1998 Oct; 76(5):584-8. PubMed ID: 9826044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auditing outcomes after treatment of Scottish patients with uveal melanoma in Liverpool.
    Wright PK; Damato BE
    J R Coll Surg Edinb; 1999 Aug; 44(4):260-4. PubMed ID: 10453150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uveal tumour resection.
    Char DH; Miller T; Crawford JB
    Br J Ophthalmol; 2001 Oct; 85(10):1213-9. PubMed ID: 11567967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Episcleral plaque radiotherapy for uveal melanoma.
    Giblin ME; Shields JA; Augsburger JJ; Brady LW
    Aust N Z J Ophthalmol; 1989 May; 17(2):153-6. PubMed ID: 2667581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland.
    Chia SN; Smith HB; Hammer HM; Kemp EG
    Eye (Lond); 2015 Jun; 29(6):748-56. PubMed ID: 25853443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
    Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
    Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant proton beam irradiation followed by transscleral resection of uveal melanoma in 106 cases.
    Willerding GD; Cordini D; Moser L; Krause L; Foerster MH; Bechrakis NE
    Br J Ophthalmol; 2016 Apr; 100(4):463-7. PubMed ID: 26224096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ocular retention in patients with uveal melanoma managed by a multimodality approach].
    García-Alvarez C; Muiños Y; Saornil MA; Almaraz A; López-Lara F; Frutos JM; Muñoz MF
    Arch Soc Esp Oftalmol; 2009 Mar; 84(3):145-9. PubMed ID: 19340720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proton beam radiotherapy of uveal melanoma--preliminary results].
    Romanowska-Dixon B; Pogrzebielski A; Bogdali A; Markiewicz A; Swakoń J; Olko P; Jezabek M; Sas-Korczyńska B; Pluta E
    Klin Oczna; 2012; 114(3):173-9. PubMed ID: 23373396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
    Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
    Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height.
    Puusaari I; Damato B; Kivelä T
    Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):522-33. PubMed ID: 17111148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoresection of large uveal melanomas: clinical results in a consecutive series of 200 cases.
    Biewald E; Lautner H; Gök M; Horstmann GA; Sauerwein W; Flühs D; Bornfeld N
    Br J Ophthalmol; 2017 Feb; 101(2):204-208. PubMed ID: 27121095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endoresection following proton beam irradiation of large uveal melanomas].
    Bechrakis NE; Höcht S; Martus P; Kreusel KM; Heese J; Foerster MH
    Ophthalmologe; 2004 Apr; 101(4):370-6. PubMed ID: 15067418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
    Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
    Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
    Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.